Who are Black Cohosh (iCR) or tibolone's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/black-cohosh-icr-or-tibolone.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Black Cohosh (iCR) or tibolone — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Black Cohosh (iCR) or tibolone (Black Cohosh (iCR) or tibolone) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal extract / Selective tissue estrogenic activity regulator (STEAR). Area: Women's Health / Endocrinology.

phase 3 Herbal extract / Selective tissue estrogenic activity regulator (STEAR) Serotonin receptors (Black Cohosh); estrogen receptor, progesterone receptor, androgen receptor (tibolone) Women's Health / Endocrinology Small molecule Live · refreshed every 30 min

Target snapshot

Black Cohosh (iCR) or tibolone (Black Cohosh (iCR) or tibolone) — Schaper & Bruemmer GmbH & Co KG. Black Cohosh (iCR) and tibolone work through different pathways—Black Cohosh may modulate serotonin and other neurotransmitters to reduce vasomotor symptoms, while tibolone acts as a selective tissue estrogenic activity regulator (STEAR) with mixed estrogenic, progestagenic, and androgenic effects.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Black Cohosh (iCR) or tibolone TARGET	Black Cohosh (iCR) or tibolone	Schaper & Bruemmer GmbH & Co KG	phase 3	Herbal extract / Selective tissue estrogenic activity regulator (STEAR)	Serotonin receptors (Black Cohosh); estrogen receptor, progesterone receptor, androgen receptor (tibolone)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal extract / Selective tissue estrogenic activity regulator (STEAR) class)

Schaper & Bruemmer GmbH & Co KG · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Black Cohosh (iCR) or tibolone — Competitive Intelligence Brief. https://druglandscape.com/ci/black-cohosh-icr-or-tibolone. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab